Euroapi SAS
PAR:EAPI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gencell Ltd
TASE:GNCL
|
IL |
|
Eurasia Mining PLC
LSE:EUA
|
UK |
|
NIIT Ltd
NSE:NIITLTD
|
IN |
|
Kuraudia Holdings Co Ltd
TSE:3607
|
JP |
|
J
|
Jiangsu Favored Nanotechnology Co Ltd
SSE:688371
|
CN |
|
Yeal Electric Co Ltd
SZSE:300923
|
CN |
|
Jentech Precision Industrial Co Ltd
TWSE:3653
|
TW |
|
Intellex Co Ltd
TSE:8940
|
JP |
|
T
|
Tidehold Development Co Ltd
TWSE:9902
|
TW |
|
Beyond Commerce Inc
OTC:BYOC
|
US |
Euroapi SAS
Operating Income
Euroapi SAS
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
Euroapi SAS
PAR:EAPI
|
Operating Income
€3.7m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sanofi SA
PAR:SAN
|
Operating Income
€10.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
|
Ipsen SA
PAR:IPN
|
Operating Income
€978.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
12%
|
|
|
Vetoquinol SA
PAR:VETO
|
Operating Income
€79.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Virbac SA
PAR:VIRP
|
Operating Income
€230.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
14%
|
CAGR 10-Years
21%
|
|
|
Medincell SA
PAR:MEDCL
|
Operating Income
-€9.9m
|
CAGR 3-Years
26%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Euroapi SAS
Glance View
EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
See Also
What is Euroapi SAS's Operating Income?
Operating Income
3.7m
EUR
Based on the financial report for Dec 31, 2025, Euroapi SAS's Operating Income amounts to 3.7m EUR.
What is Euroapi SAS's Operating Income growth rate?
Operating Income CAGR 3Y
-49%
The average annual Operating Income growth rates for Euroapi SAS have been -49% over the past three years .
